Introduction
Sex cord-stromal tumors are the second most frequent category of testicular neoplasms, accounting for approximately 2-5% of cases in adults; however, they make up approximately 25% of cases that occur in infants and children [1] . The incidence of sex cord-stromal tumors is lower in the testis than in the ovary, and the frequency of the different histological types varies substantially between the gonads [2, 3] . In the ovary, sex cord-stromal tumors account for approximately 6% of all primary ovarian neoplasms, and about half of these are in the fibromathecoma group [4] . The sex cord-stromal tumor category consists of neoplasms that are composed of granulosa cells, fibroblasts, theca cells, Sertoli cells, or Leydig cells, either singly or in various combinations.
Both genetic and epigenetic factors account for the significant differences in frequency and histologic composition between the different types of testicular and ovarian sex cord-stromal tumors. Thus, testicular sex cord-stromal tumors more frequently are composed of Sertoli or Leydig cells, whereas ovarian examples are composed more frequently of granulosa or theca cells. Paradoxically, however, Sertoli-Leydig cell tumor is rare in the testis, but accounts for 0.5% of all ovarian neoplasms [4] . Juvenile-type granulosa cell tumor is rare, accounting for < 0.5% of all testicular sex cord-stromal tumors; however, it is the most common testicular neoplasm in the first 6 months of life, and almost all cases occur in the first decade [1] . Although exceptions exist, tumors that are less differentiated or contain a sex cord component are more likely to show clinically aggressive behavior than those that are better differentiated or composed of only stromal elements. Precursor lesions for neoplasms in the sex cord-stromal tumor category have not been identified.
The latest World Health Organization (WHO) classification of tumors of the testis divides sex cord-stromal tumors into 2 categories: 1) pure sex cord or pure stromal tumors and 2) those that are composed of an admixture of sex cord and stromal elements [1] . Although the nomenclature would suggest that both adult and juvenile types of granulosa cell tumor are pure
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neoplasms, in reality, each type sometimes contains a neoplastic theca cell component. We prefer to divide sex cord-stromal tumors into those showing predominantly testicular, ovarian, or indeterminate differentiation (Table) . Although the nomenclature for testicular and ovarian sex cord-stromal tumors is similar for the most part, certain nuances exist. For example, the equivalent of testicular Sertoli cell tumor, not otherwise specified (NOS) is simply Sertoli cell tumor in the ovary because, thus far, no other types have been described. Leydig cell tumor and Sertoli cell tumor are the two most common sex cord-stromal tumors in adult men, although both neoplasms are, in fact, uncommon. Several histological types of ovarian sex cord-stromal tumors are characterized by somatic DICER1 hotspot mutations; however, such mutations were not detected in 15 testicular sex cord-stromal tumors [5] .
Although the existence of the entity of mixed germ cell-sex cord stromal tumor (MGC-SCST) of the testis has been challenged, the most recent evidence supports its existence;
however, testicular neoplasms differ significantly in histological appearance and clinical behavior from ovarian examples due to both genetic and epigenetic factors [6, 7] .
Sex cord-stromal tumors

Sertoli cell tumor
Sertoli cell tumor is rare in either gonad; however, testicular examples are about twice as frequent as those occurring in the ovary. Sertoli cell tumor can occur throughout life; but tends to be detected at an older age in men (mean 45 years) than in women (mean 30 years) [8, 9] .
Clinical symptoms at presentation are usually nonspecific. Hormonal manifestations in patients, such as gynecomastia in males and isosexual pseudoprecocity in girls, are uncommon. Most
Sertoli cell tumors are clinically benign; however, approximately 7% of testicular examples have metastases at presentation, whereas 11% (3 of 27 cases) of stage I ovarian tumors had pelvicabdominal recurrences within 9-36 months [8] [9] [10] . In the current WHO classification of testicular tumors, 3 histological variants of Sertoli cell tumor are recognized: Sertoli cell tumor, NOS, large
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cell calcifying Sertoli cell tumor, and intratubular large cell hyalinizing Sertoli cell neoplasia [1] .
Sertoli cell tumor, NOS occurs in either sex, whereas the 2 other subtypes have not been described in the ovary; thus, it is unnecessary to subtype ovarian Sertoli cell tumors [1, 11] . The histological appearance of Sertoli cell tumor, NOS of the testis and ovarian Sertoli cell tumor is strikingly similar; however, it is more difficult to establish a consistent morphological profile of ovarian Sertoli cell tumor because of the existence of more mimics. Immunohistochemistry is generally required for the diagnosis of ovarian Sertoli cell tumors, but it is of limited value in the distinction of ovarian Sertoli cell tumor from granulosa cell tumor, where morphological features remain the mainstay for diagnosis, particularly their patterns of cellular arrangement and their nuclear appearance. Recent observations indicate that molecular studies can greatly aid in this distinction [12] [13] [14] [15] .
Sertoli cell tumor, NOS
Testicular Sertoli cell tumor is about twice as common as ovarian examples. Sertoli cell tumor, NOS demonstrates CTNNB1 mutations (the gene that encodes. β-catenin) in > 70% of neoplasms [1, 15] . About 40% of cases show gain in the X chromosome [16] . Sertoli cell tumor, NOS is usually well circumscribed and tan-white to yellow on macroscopic examination (Fig.   1A) . A lobular or nodular appearance at low magnification is distinctive in the betterdifferentiated testicular and ovarian tumors. Histological examination typically shows a spectrum ranging from a well-differentiated tubular pattern to a diffuse solid proliferation. Rarely, alveolar or retiform patterns are seen. Lymphocytic infiltrate in testicular Sertoli cell tumor can occasionally lead to the mistaken diagnosis of seminoma [1] . Sertoli cell tumors usually have pale to eosinophilic cytoplasm but sometimes consists of lipid-rich cells, and the term lipid-rich Sertoli cell tumor is appropriate for those neoplasms composed entirely of lipid-rich cells [8, 9] .
This variant, however, is observed mostly in the ovary and is associated with isosexual pseudoprecocity in girls.
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Because testicular Sertoli cell tumor, NOS contains variable amounts of lipid; such neoplasms are no longer considered to be a separate entity (Fig. 1B) [17] . We recently encountered a case of lipid-rich Sertoli cell tumor, NOS with signet ring cells, an unusual finding (Fig. 1C) . Two similar cases were reported as signet-ring stromal tumor of the testis [18, 19] .
Although the World Health Organization referenced the latter cases, a category of signet-ring stromal tumor of the testis was not included in the latest classification of testicular tumors [1] . We believe that the 2 cases previously reported as signet-ring stromal cell tumor of the testis are more accurately classified as Sertoli cell tumor, NOS with a lipid-rich pattern and signet ring cells.
Signet ring stromal cell tumor of the ovary differs significantly from the above-described testicular cases in that the former arises from spindle-shaped immature gonadal stromal cells and the vacuoles in the signet ring cells are hydropic rather than containing lipid [20, 21] . The term signet ring stromal cell tumor was chosen specifically to indicate origin of the neoplasm from ovarian stroma. Lipid-containing signet ring cells have previously been described in different types of ovarian sex cord-stromal tumors, including thecoma, and sclerosing stromal tumor [20, 21] .
In the testis, sclerosing Sertoli cell tumor, although originally classified separately, is now considered to be a variant of Sertoli cell tumor, NOS [1, 22] . Sclerosing Sertoli cell tumor is rare in the testis; it has not been reported as a separate entity in the ovary, but has been clearly illustrated [8, 9] . This testicular variant is typically small (80% < 2 cm) and well circumscribed.
In most cases, it is characterized by solid or hollow tubules and/or long anastomosing cords in a hypocellular, densely sclerotic stroma. By definition, at least 50% of the neoplasm must consist of hyalinized stroma in order to establish the diagnosis of this variant [22] . Entrapped seminiferous tubules are frequently found in the neoplasm.
Sclerosing Sertoli cell tumors < 2 cm in greatest dimension and lacking histological features associated with malignancy have a negligible risk of metastasis and are adequately managed by orchiectomy alone [22] . Only 2 malignant examples have been reported, one
displaying histological malignancy including cytologic atypia, frequent mitoses, vascular invasion, and invasive extratesticular growth, whereas another was clinically aggressive with bone metastasis and the subsequent death of the patient from disease [22, 23] . The occurrence of mutations of the CTNNB1 gene and nuclear displacement of β-catenin in both Sertoli cell tumor, NOS and its sclerosing variant support their close relationship [1, 15] .
Two or more of the following features: tumor size ≥ 5 cm, moderate to severe nuclear atypia, 5 or more mitoses per 10 high power fields, vascular invasion, and tumor necrosis are associated with adverse outcomes in testicular Sertoli cell tumor, NOS; however, only two of these features, moderate to severe nuclear atypia and 5 or more mitoses per 10 high power fields are useful indicators for a poor prognosis in corresponding ovarian neoplasms (Figs. 1D-F) [8, 9] .
Sertoli cell tumor, NOS must be distinguished from macroscopic Sertoli cell nodule. The latter lesion either presents as a palpable testicular mass or is found incidentally on ultrasound and measures ≥ 0.5 cm [24, 25] . The largest macroscopic Sertoli cell nodule thus far published measured 1.7 cm in greatest dimension and contained numerous spermatogonia [26] .
Histologically, macroscopic Sertoli cell nodule is composed of clusters of altered seminiferous tubules separated by testicular interstitial tissue. The altered tubules contain an admixture of immature Sertoli cells, variable numbers of spermatogonia, and globular deposits of basement membrane material at all levels of the involved tubules.
Large cell calcifying Sertoli cell tumor
Large cell calcifying Sertoli cell tumor has only been reported in the testis. Cases typically occur in teenage boys and young adults, and about 60% are sporadic [1] . Approximately 40% of cases are bilateral, and these are nearly always associated with the Carney complex.
Germline mutations in the PRKAR1A gene on the long arm of chromosome 17 are found in a high proportion of Carney complex type 1-associated neoplasms and occasionally in apparently sporadic examples [27] .
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Histologically, the tumor cells are arranged in solid tubules, nests, cords, or clusters.
Calcification is the only distinctive macroscopic feature ( Fig. 2A) . As indicated by its name, the neoplastic cells are large and have abundant eosinophilic cytoplasm (Fig. 2B) . About one-half of the neoplasms contain an intratubular component. The cytological features closely resemble those of Leydig cell tumor; however, the presence of calcification, the absence of Reinke crystals, the prominent tubular architecture, and larger cell size are sufficient for the differential diagnosis [28] . Clinically aggressive behavior is uncommon. Malignant large cell calcifying Sertoli cell tumors have 2 or more of the following features: extratesticular spread, tumor size ≥ 4 cm, mitoses > 3 per 10 high power fields, significant nuclear atypia, necrosis, lymphatic or blood vascular invasion [29, 30] .
Intratubular large cell hyalinizing Sertoli cell neoplasia
Intratubular large cell hyalinizing Sertoli cell neoplasia is a distinct variant of Sertoli cell tumor that occurs almost exclusively in boys with the Peutz-Jeghers syndrome [31] . Calcification occurs occasionally in the basement membrane material. Because of its typical intratubular location, metastases are unlikely to occur. Uncommonly, these neoplasms invade the testicular interstitium and, thereby, histologically resemble large cell calcifying Sertoli cell tumor.
The corresponding tumor in girls with the Peutz-Jeghers syndrome is known as sex cord tumor with annular tubules [10] . The histological differences between testicular intratubular large cell hyalinizing Sertoli cell neoplasia and ovarian sex cord tumor with annular tubules are likely
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related to both genetic and epigenetic factors.
Leydig cell tumor
Leydig cell tumors comprise 1-3% of testicular neoplasms and can occur at any age, but are more common in prepubertal boys and in men aged 30 to 60 years. These neoplasms can produce androgens or estrogens, and about 30% of patients present with gynecomastia. Leydig cell tumors are always benign in boys, whereas 10% of the cases in adults are malignant [32, 33] .
On the sectioned surface, these neoplasms are red-brown to yellow. Histologically, seminiferous tubules are often entrapped at the periphery of the tumor ( [30] .
In a series of 40 cases of testicular Leydig cell tumor, all 5 clinically malignant cases had 4 or more of the above histological features [32] .
Sertoli-Leydig cell tumor
Sertoli-Leydig cell tumors are exceptionally rare in the testis, whereas they account for 0.5% of ovarian neoplasms [10] . Six previously reported putative cases that contained both tubular and Leydig cell components were recently reviewed, however, the diagnosis could not be definitely confirmed because of the lack of immunocytochemical stains and high quality images [30] . At least 1 documented well-differentiated Sertoli-Leydig cell tumor involving the testis has been reported [34] . Furthermore, a moderately differentiated neoplasm was recently illustrated in the recent WHO Classification of Tumours of the Urinary System and Male Genital Organs (see Fig. 4 .63, p.228) [1] .
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Because of its rarity in the testis, our knowledge of this neoplasm comes almost exclusively from the ovarian entity. Sertoli-Leydig cell tumors can be divided into three main Retiform areas typically show a network of irregularly branching, elongated slit-like tubules and cysts. Papillae or polypoid structures can project into these structures.
Granulosa cell tumor
Granulosa cell tumors are currently classified into adult and juvenile types based on their histological appearance; they are much more common in the ovary than in the testis. Granulosa
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cell tumors of either adult or juvenile type are almost invariably unilateral. The adult type accounts for 95% of ovarian granulosa cell tumors, whereas, in the testis, the 2 types have a more balanced distribution. In the testis, juvenile-type granulosa tumor is the most common neoplasm in the first 6 months of life.
Testicular granulosa cell tumor is rare, although corresponding ovarian neoplasms are the most common malignant sex cord-stromal tumor, accounting for approximately 12% of cases [4, 30] . Although the term granulosa cell tumor connotes that it is composed purely or at least predominantly of granulosa cells, in reality, both the juvenile and adult types occasionally have a neoplastic theca cell component.
Adult-type granulosa cell tumor
Adult-type granulosa cell tumor is rare, accounting for < 0.5% of testicular sex cordstromal tumors [1] . The neoplasms are almost invariably unilateral. Testicular and ovarian adulttype granulosa cell tumors not only have a similar FOXL2 codon 134.
Macroscopically, adult-type granulosa cell tumor typically appears as a solid, cystic, or solid and cystic mass with a yellow-tan hue on the sectioned surface. Histologically, the diffuse and microfollicular patterns, the latter with Call-Exner bodies, are the most common in testicular examples [35] . 
Juvenile-type granulosa cell tumor
Juvenile-type granulosa cell tumor is rare, accounting for < 0.5% of all testicular SCSTs;
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however, it is the most common testicular neoplasm in the first 6 months of life, and almost all cases occur in the first decade [1] . All neoplasms reported to date have been benign.
On macroscopic examination, these tumors are well circumscribed and vary from solid to cystic. The sectioned surface varies from yellow to tan-white. Histological examination shows a solid pattern with focal follicular formation or a uniformly follicular pattern (Fig. 4A) . The follicles contain basophilic or eosinophilic fluid that stains with mucicarmine and are lined by an inner layer of granulosa cells sometimes surrounded by an outer layer of neoplastic theca cells (Figs. 4B) . Occasionally, the granulosa cells appear to be luteinized. The neoplastic granulosa cells are distinguished from those of the adult type in that they have round dense nuclei that lack nuclear grooves. Mitotic figures are more frequent than in the adult type. Classical Call-Exner bodies and pale or grooved nuclei are not encountered. The primary differential diagnosis is juvenile-type yolk sac tumor. Juvenile-type granulosa cell tumor is almost always positive for steroidogenic factor 1, whereas SALL4, glypican-3, and alpha-fetoprotein are negative in the neoplastic granulosa cells.
Tumors in the fibroma group
Although the fibroma-thecoma group accounts for at least 4% of ovarian tumors, < 30
cases have been reported in the testis [36] [37] [38] . In the interest of scientific parsimony, we prefer the terminology recommended in the WHO classification of ovarian tumors [11] . To the best of our knowledge, no cases of thecoma or sclerosing stromal tumor have been reported in the testis; therefore, the term fibrothecoma used in the latest WHO classification of testicular tumors does not seem appropriate [1] . Thus, we diagnose testicular neoplasms in this group simply as fibroma or cellular fibroma. None of the tumors reported thus far have been clinically aggressive [36, 37] .
These neoplasms occur mostly in middle aged or elderly men and are almost invariably unilateral. On the sectioned surface, they are well circumscribed and white. Entrapped seminiferous tubules are occasionally encountered at the periphery of the neoplasm (Fig. 5A) .
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Histological examination of typical and cellular fibroma shows oval to spindle-shaped cells arranged in a fascicular or storiform pattern sometimes containing fibrous bands or hyaline plaques [36] (Fig. 5B) . The nuclei of cellular fibromas are more densely packed and mitotically active, containing as many as 5 mitotic figures per 10 high power fields, and hyaline plaques also can occur [37] (Figs. 5C and D) .
Myoid gonadal stromal tumor
Myoid gonadal stromal tumor is classified as an emerging entity in the latest WHO classification of testicular tumors despite the fact that it was first reported as such in 1991; to date, < 10 cases have been reported [1] . Although this tumor can occur at almost any age, the typical presentation is a testicular mass in a young or middle-aged man. All cases reported to date have had an uneventful follow up. Thus far, no corresponding neoplasm has been described in the ovary.
Myoid gonadal stromal tumor is composed of densely packed spindle-shaped cells arranged in short fascicles that have features of both smooth muscle and gonadal stroma [39] . The existence of such a neoplasm is not altogether unexpected since ovarian stroma and granulosa cell tumor, thecoma, and fibroma are all known to show smooth muscle differentiation to varying degrees, however for the same reason we consider the concept to be problematic [40] .
In 1977, Evans and Glick [41] reported the first case as an unusual gonadal stromal tumor that occurred in a 4-year old boy. In, 1984, Greco et al. [42] reported 2 cases as testicular stroma tumor with myofilaments. In 1991, Weidner [43] introduced the term myoid gonadal stromal tumor, and, in 2012, Du et al. [44] of the same group compared their findings in another case to the normal adjacent peritubular myoid cells and observed similar immunoreactivity. They believed that myoid gonadal stromal tumor shows peritubular myoid cell differentiation.
In 1996, Nistal et al. [45] reported a case as fusocellular gonadal stroma tumor of the testis with epithelial and myoid differentiation and suggested origin from peritubular myoid cells.
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The challenge of establishing a diagnosis of myoid gonadal stromal tumor was exemplified by Jones et al. [36] who interpreted the aforementioned case as a fibroma of gonadal stromal origin.
In 1997, Renshaw et al. [46] We believe that further study of this rare and enigmatic tumor is necessary to verify its existence as a distinct entity, to establish its histogenesis, and to develop reliable histological and immunocytochemical criteria that can distinguish it from other pure testicular stromal neoplasms, particularly testicular fibroma.
Unclassified and mixed sex cord-stromal tumors
Unclassified and mixed sex cord-stromal tumors are rare in the testis. They are best considered to be in the indeterminate category because they lack predominant differentiation in either the testicular or ovarian direction. Although they can occur at any age, they typically present in middle-aged or elderly men [1] . Approximately one-third of cases, however, present in children [30] . The usual presentation is a painless testicular mass.
The unclassified type consists of sex cord elements having features intermediate between
Sertoli and granulosa cells as well as stromal elements (Figs. 6A and B) . The mixed type consists
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of various combinations of sex cord elements that show differentiation either toward Sertoli cells or granulosa cells from area to area. Reticulin stains can be helpful in the diagnosis of unclassified or mixed sex cord stromal tumor since the sex cord elements have inconspicuous reticulin fibers, whereas reticulin surrounds individual stromal cells. Occasional neoplasms in either category are clinically malignant, and these display similar histological features to those used to distinguish malignant Sertoli cell or Leydig cell tumors from benign examples [1] . To the best of our knowledge, no case corresponding to gynandroblastoma has been described in the testis, although such neoplasms occur rarely in the ovary.
Tumors composed of both germ cells and sex cord-stromal derivatives
In the latest classification of testicular neoplasms, the WHO includes a category of tumors containing both germ cells and sex cord-stromal elements immediately after that of sex cord-stromal tumors [1] . We include both gonadoblastoma and MGC-SCST in this category, although the latter was excluded from the fourth edition of the WHO classification of tumors of the testis. Because of differing viewpoints in the literature regarding the existence of testicular MGC-SCST, the Editors deemed that there was insufficient evidence at the time of publication to include the category of MGC-SCST in the WHO classification [47] . However, we believe that the findings in recent articles strongly support the existence of testicular MGC-SCST as a distinct entity [7, 48, 49] .
Gonadoblastoma
Clinical findings
In 1953, Scully [50] first described classical gonadoblastoma. Later, in a seminal article, he reported a series of 74 cases [51] . Gonadoblastoma occurs almost entirely in the dysgenetic gonads of individuals who have a disorder of sex development associated with a Y-chromosome or part thereof [52] . Approximately 20% of gonadoblastomas occur in phenotypic males, who are
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most often < 20 years of age [30] . The clinical presentation in the latter cases commonly includes cryptorchidism, hypospadias, and gynecomastia [51] . Gonadoblastoma occurs predominantly in phenotypic females with gonadal dysgenesis and an abnormal karyotype, but occurs exceptionally in apparently normal females with a 46 XX karyotype [11] . The most common predisposing conditions are 45, X/46, XY partial gonadal dysgenesis, 46, XY complete gonadal dysgenesis, and 46, XY disorder of sex development, formerly known as male pseudohermaphroditism [52, 53] . In a patient with a disorder of sex development, at least 1 gonad is developmentally abnormal; however, histological confirmation would not be possible if the gonad has been completely replaced by neoplasm.
The gonadoblastoma susceptibility region on the short arm of the Y chromosome (GBY)
is the only oncogenic region on the human Y chromosome and predisposes the dysgenetic gonads of XY individuals to develop an in situ tumor; TSPY1 is the putative gene [52, 54, 55] . If a gonad in a patient who has a disorder of sex development contains germ cells with delayed maturation and also harbors the TSPY1 gene, the cells may undergo transformation to gonadoblastoma [56] .
The germ cells that have delayed maturation express OCT4 [57] .
Histology and immunocytochemistry
Classical gonadoblastoma is a noninvasive neoplasm composed of cellular nests or islands surrounded by gonadal stroma of variable cellularity. About 40% of gonadoblastomas are bilateral [1] . Histologically, the nests are composed of germ cells intimately admixed with immature sex cord derivatives, and the latter often surround hyaline basement membrane deposits (Fig. 7A) . In some instances, stromal steroid cells are noted. The germ cells of individual cases of gonadoblastoma are heterogeneous, being composed of both mature and immature germ cells [58] . The mature germ cells resemble spermatogonia and express TSPY1, whereas the immature germ cells resemble those of germinoma, express OCT4, and are considered to be the precursor of the malignant germ cell neoplasms associated with gonadoblastoma [59] .
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Frequently, classical gonadoblastoma shows involutional changes including deposits of basement membrane material, hyalinization, and calcification ( Figure 7B) . Rarely, the involutional changes are extensive resulting in a calcified mass without any viable neoplastic cells. We refer to such cases as involuted gonadoblastoma; although such cases were originally described as "burnt out" gonadoblastoma [51] .
Undifferentiated gonadal tissue
Undifferentiated gonadal tissue is defined as gonadal tissue containing germ cells not enclosed in seminiferous tubules or follicles that either resides without apparent organization in a background of cellular gonadal stroma or is organized together with sex cord elements into cordlike structures [57, 60] . Undifferentiated gonadal tissue occurs exclusively within dysgenetic gonads and has been proposed as the precursor of classical gonadoblastoma [57, 61] . In 67% of cases of classical gonadoblastoma that contained adjacent gonad, undifferentiated gonadal tissue was identified [57] . The germ cells in both undifferentiated gonadal tissue and classical gonadoblastoma are heterogeneous; they can express TSPY1, OCT4, or can co-express the two [57] .
Relationship of classical gonadoblastoma to malignant germ cell tumors
Classical gonadoblastoma represents the precursor of germinoma and other invasive malignant germ cell neoplasms in patients who have a disorder of sex development [62] . Thus, classical gonadoblastoma can be interpreted as an in situ germ cell neoplasm that occurs in dysgenetic gonads that are predisposed to malignant transformation, most commonly to germinoma [59] . In 60% of cases of classical gonadoblastoma, an associated malignant germ cell tumor is encountered, and in 80% of the latter cases, the neoplasm is germinoma (Figs. 7B) [4] .
However, patients with classical gonadoblastoma sometimes develop a more aggressive germ cell tumor, including yolk sac tumor, embryonal carcinoma, or immature teratoma [63] . SALL4 is
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diffusely expressed in the germ cells of both gonadoblastoma and germinoma (Figs. 7C) .
Ulbright and Young [64] recently reviewed gonadoblastoma and other selected aspects of gonadal pathology in patients that have a disorder of sex development.
"Dissecting gonadoblastoma"
In a recent investigation of 50 cases of classical gonadoblastoma, Kao et al. [65] described a morphologic variant in 38 cases that they referred to as "dissecting gonadoblastoma."
They considered "dissecting gonadoblastoma" to be a variant of classical gonadoblastoma that showed similar immunohistochemical findings. In their model, classical gonadoblastoma was believed to be the intermediate lesion between the cord-like/anastomosing phase and the solid/expansile form of "dissecting gonadoblastoma."
The prime importance of this variant is that several growth patterns in which the number of sex cord cells appear reduced can be misinterpreted as germinoma [65] . They described 3 patterns: solid expansile, anastomosing, and cord-like. The cord-like pattern can be confused with a similar pattern that has been described in germinoma resulting in more aggressive clinical treatment than necessary (Fig. 7D) [30] . The application of inhibin or steroidogenic factor 1 immunohistochemical stains facilitates the identification of residual sex cord elements and is often useful in distinguishing "dissecting gonadoblastoma" from germinoma [65] .
Distinction of undifferentiated gonadal tissue from "dissecting gonadoblastoma"
At the present time, the relationship of "dissecting gonadoblastoma" to undifferentiated gonadal tissue is controversial and unresolved. We believe that it is preferable to continue to use the term undifferentiated gonadal tissue for those cases that are considered to be the precursor of gonadoblastoma, as was recommended in the latest WHO classification of testicular tumors (p. 237), and to limit the use of "dissecting gonadoblastoma" to those cases with a solid expansile, cord-like, or other patterns that can be confused with germinoma [1] . We consider clonal
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expansion of germ cells in "dissecting gonadoblastoma" to be the likely immediate precursor of some germinomas, and, therefore, such expansion should be a requirement for the diagnosis of "dissecting gonadoblastoma."
Undifferentiated gonadal tissue has been described morphologically as germ cells with delayed development within immature sex cords or isolated in the interstitium [57, 60] .
Undifferentiated gonadal tissue is by definition a non-neoplastic process and, therefore, should be distinguished from "dissecting gonadoblastoma," as the latter is a neoplastic process that is sometimes the precursor of germinoma. Although a cord-like pattern is a feature of some examples of undifferentiated gonadal tissue and some "dissecting gonadoblastomas," the distinction can be made histologically by careful examination of other features of "dissecting gonadoblastoma" including an expansive growth pattern and proliferation of transformed germ cells.
Mixed germ cell-sex cord stromal tumor
In contrast to gonadoblastoma, MGC-SCST occurs in phenotypically normal individuals without sex chromosomal abnormalities, and both gonads are developmentally normal [53] .
MGC-SCST shows significant differences in frequency, histological appearance, and biological behavior depending on whether the neoplasm originates in the testis or the ovary. Both genetic and epigenetic factors likely account for these dissimilarities.
In 1972, Talerman [66, 67] described separately the first 2 cases of ovarian MGC-SCST.
Nearly 10 years later, Bolen [68] reported the first testicular case. Testicular MGC-SCST is often composed of an intimate mixture of germ cells and sex-cord derivatives; however, the germ cells are variable in quantity and distribution, occasionally making the diagnosis challenging.
Only 10% of cases in girls and women are associated with malignant germ cell tumors, far less than the incidence in classical gonadoblastoma (50-60%). Intriguingly, testicular cases have not been found to be associated with clinically malignant germ cell tumors to date [7, 69] .
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However, a case of MGC-SCST in a 7-year-old boy with precocious pseudopuberty contained some histologically and immunohistochemically malignant germ cells resembling those of seminoma as well as immature sex cord elements [70] . The seminoma-like germ cells likely occurred as a result of an additional mutation in the germ cells of the neoplasm.
Macroscopically, testicular MGC-SCSTs are variable in size, well delimited, and solid gray-white on the sectioned surface (Fig. 8A) . Testicular MGC-SCSTs often contain entrapped seminiferous tubules in which the germ cells are confined to the basal compartment (Fig. 8B) .
Occasionally, an intratubular component is identified (Fig. 8C) . The intratubular component shows clonal expansion of germ cells and has been shown to be the precursor of invasive MGC-SCST in a few cases [7] . In a majority of cases of invasive MGC-SCST, the germ cells form an integral part of the neoplasm (Fig. 8D) . Histologically, MGC-SCST lacks the nest-like pattern and the involutional changes of basement membrane deposition, hyalinization, and calcification that are often observed in classical gonadoblastoma.
Although the existence of the entity of MGC-SCST of the testis has been challenged, the most recent evidence strongly supports its occurrence; however, testicular tumors differ significantly from ovarian examples both in their biological behavior and their histological appearance [6, 7, 48, 49] .
Conclusion
For the most part, the testis and ovary share similar categories of sex cord-stromal tumors; however, for specific categories, the neoplasms have different frequencies, subtypes, and clinicopathological features. Our knowledge of sex cord-stromal tumors has advanced in recent years incorporating the description of some novel morphological variants, the discovery of the FOXL2 mutation in granulosa cell tumors and some other sex cord-stromal tumors, and DICER1 somatic mutations in several types of ovarian sex cord-stromal tumors, but not so far in similar testicular neoplasms.
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Careful morphologic observations together with detailed clinical information remain fundamental for the diagnosis of gonadal sex cord-stromal tumors and those that have an additional germ cell component. Although our knowledge of the pathobiology and molecular genetics of these neoplasms will increase in the future, incorporation of classical histopathology and immunocytochemistry will result in optimal patient care. Thus, we believe that diagnostic pathologists will play an essential role in this process for the foreseeable future 
